Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis October 14, 1996
Receptor binding profile suggests multiple mechanisms of action are responsible for ibogaine's putative anti-addictive activity April 2, 1995
Differences Between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens January 1, 1986
Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca April 1, 1984
